Lianren Health, Recognized as Shanghai 'Specialized, Sophisticated, Distinctive, and Innovative' Enterprise, Files IPO Prospectus

At the Start of 2023, Health and Medical Big Data EnterprisesLIANREN Digital HealthGood news keeps coming: after being listed among “China’s Potential Unicorns” for the first time, the company has now been recognized as a Shanghai “Specialized, Refined, Differential, and Innovative” (SRDI) enterprise.

This emerging player carries a distinct set of labels that set it apart from many of its predecessors: unified deployment under the National Health Commission, state-owned capital as the main body but with market-oriented mechanisms, strong shareholder resources, and a core team with extensive industry experience and diverse backgrounds. In less than four years, it hasHealthcare Data Aggregation, Data Governance, and Data Operationshas established strong competitiveness, built two closed loops comprising healthcare services and diversified innovative payment models, and covered five major application scenarios: “benefiting the people, supporting government initiatives, aiding medical professionals, facilitating research, and empowering enterprises.”

“Specialized, refined, distinctive, and innovative” (SRDI) enterprises are highly expected to address the “chokepoint” issues. They typically operate in niche segments of the industrial chain and possess significant bargaining power. In 2022, the term “SRDI” was included in the Government Work Report for the first time. Cultivating small and medium-sized enterprises (SMEs) to develop into SRDI entities has become a crucial component of China’s efforts to promote industrial innovation and strengthen and supplement supply chains, elevating this initiative to the level of national strategy.

LIANREN Digital Health’s recognition as a Shanghai “Specialized, Refined, Differential, and Innovative” (SRDI) enterprise affirms its comprehensive capability to tackle persistent healthcare challenges by focusing on medical big data, leveraging robust innovation capabilities and core technologies. From an industry perspective, the accreditation of representative companies like LIANREN reflects the growing efficacy of the medical big data sector in driving economic development and strengthening and supplementing industrial chains.

Figure | Screenshot of the public notice for the 2022 list of “Specialized, Refined, Differential, and Innovative” enterprises in Shanghai

At the beginning of the year, LIANREN Digital Health was listed for the first time in the “2022 China Potential Unicorn Enterprises Report” authoritatively released by Great Wall Strategy Consulting, becoming a newly added “potential unicorn.”

Potential unicorn enterprises refer to companies that achieve a post-money valuation of $100 million in their last funding round within five years of establishment, or reach a post-money valuation of $500 million within nine years. Potential unicorns serve as the reserve force for unicorn enterprises and represent new species with significant development potential and growth prospects.

LIANREN Digital Health was established in November 2019, securing investments from institutions including China Mobile, China Pacific Insurance, Jinan International Medical Center, Shanghai Pudong Investment Holding Sci-Tech Innovation Fund, Bank of Communications, Inspur Group, United Imaging Healthcare, and Jiahua Meikang. LIANREN Digital Health has disclosed that its corporate valuation has far exceeded the threshold for potential unicorns, with a growth rate that is rare within the industry. How, then, did LIANREN Digital Health rapidly ascend to “potential unicorn” status? The answer lies in its corporate profile.

Figure | LIANREN Digital Health Headquarters

LIANREN Digital Health’s state-owned enterprise background and robust shareholder base provide a steady influx of resources.LIANREN Digital Health is China’s first health and medical big data industrial group characterized by a structure led by central state-owned enterprises, with participation from local governments, financial institutions, and healthcare IT companies, featuring state-owned capital as the main body and market-oriented mechanisms. It implements the national strategies of “New Infrastructure” and “market-based allocation of production factors,” demonstrating advanced and sustainable features in strategic planning, design, and execution.

In terms of shareholder resources, LIANREN Digital Health can aggregate the resource advantages of its eight major investors, including China Mobile and China Pacific Insurance, in medical technology, healthcare informatization, health insurance, medical big data, and commercial channels, providing significant support for core product and service development, key business expansion, industry reputation, and market influence.

Furthermore, LIANREN Digital Health boasts a management team with extensive industry experience and diverse professional backgrounds, as well as a core team of mid-level executives from leading companies in the pharmaceutical, insurance, and health informatics sectors. This robust talent pipeline has enabled LIANREN Digital Health to achieve a high degree of alignment between strategic decision-making and operational execution.

Data capabilities and the technological innovation power of “Five Kernels, Six Databases” constitute LIANREN Digital Health’s “moat.”. Leveraging its first-mover advantage in the industry, LIANREN Digital Health has developed a suite of secure, efficient, and precise mature processes and data tools. These solutions ensure both high-efficiency, accurate data aggregation and governance, as well as comprehensive data and information security throughout the entire workflow, when addressing heterogeneous, massive, and complex healthcare data.

“The Five Kernels and Six Repositories” best embody the differentiated advantages of LIANREN Digital Health’s technological innovation capabilities.The “Five Ren” is a sophisticated, advanced big data engine comprising RenCloud, RenData, RenMed, RenChip, and RenHealth. The “Six Databases” refer to LIANREN Digital Health’s proprietary six health and medical knowledge bases, which include the Disease Database, Drug Database, Prescription Database, Physician Database, Chronic Disease Database, and Health Factor Database. The deep integration of these two components empowers LIANREN Digital Health to better create data value and drive industry advancement.

A metaphor can more clearly illustrate the uniqueness of the “Five Kernels and Six Repositories.” If “source data” is likened to unprocessed ore, the “Five Kernels” serve as an integrated ore-processing machine, while the “Six Repositories” act as fuel tanks providing power. Once the machine is operational, data ore is fed in and undergoes highly automated processing. At the output end, it is transformed into well-structured metal powders—such as gold, silver, copper, and iron—which are sorted by category. These materials are then further processed into various data product “applications,” including gold jewelry, silver tableware, copper cables, and steel rebars. This highly automated data processing capability constitutes a differentiated advantage held by LIANREN Digital Health, enabling it to consistently remain among the industry’s top tier.

A stable and sustainable business model enables LIANREN Digital Health to avoid the “unicorn bubble.”Amid the profound changes unseen in a century, compounded by the impact of COVID-19, U.S. inflation and interest rate hikes, and sluggish stock prices, the bubble surrounding unicorns without viable profit models is bursting. For today’s unicorn companies, the market and investors are placing greater emphasis on fundamentals—specifically, whether they possess a genuine profit model.

In commercial applications, LIANREN Digital Health places data at its core, building a full-lifecycle, comprehensive digital health service platform centered on data integration, governance, and application. By promoting the coordinated development of healthcare, pharmaceuticals, and medical insurance, it enhances medical efficiency, improves care quality, and supports medical security, thereby truly assisting the government, serving the healthcare sector, driving industry growth, and benefiting the public.

Specifically, in the healthcare sector, LIANREN Digital Health provides regional data platform products and services to Health Commissions, and offers disease-specific databases, medical research platforms, hospital data platforms, telemedicine, and data storage and high-performance computing platforms to hospitals. For the pharmaceutical industry, it delivers data-driven clinical R&D and marketing empowerment services. In the insurance sector, it provides data-driven precision marketing and intelligent risk control services to Healthcare Security Administrations and insurance companies. Additionally, for corporate employees and individual consumers (C-end), it has established value-added health management services centered on “assessment, monitoring, management, prevention, and treatment,” primarily through G2C and B2C models.

Corporate management involves a continuous feedback process; being listed on the “Potential Unicorn” list and being recognized as a Shanghai “Specialized, Refined, Differential, and Innovative” enterprise constitute positive feedback received by LIANREN Digital Health.

As is well known, “innovation” is the common soul of “specialized, refined, distinctive, and innovative” enterprises. Specifically, for LIANREN Digital Health, in addition to the corporate advantages mentioned above“Tangible patents, high technical barriers, and integration capabilities across the upstream and downstream of the industry” also constitute its “hard barriers.”

Intellectual property rights serve as a key benchmark for evaluating the innovation capacity and proficiency of specialized, refined, distinctive, and innovative enterprises. According to data from Patsnap, the 245 enterprises in Shanghai’s fourth batch of specialized and sophisticated “Little Giant” firms have filed a total of over 28,000 patent applications, averaging approximately 116 applications per company. LIANREN Digital Health has filed more than 200 invention patent applications (including those pending), significantly exceeding the Shanghai average. This robust intellectual property portfolio is one of the key factors enabling LIANREN Digital Health to establish strong technological barriers.

In terms of industry chain integration, LIANREN Digital Health places itself at the core and leverages shareholder resources to expand outward, integrating the medical care, pharmaceutical, and health insurance sectors into a cohesive ecosystem. This fosters a more scalable, networked business structure that enables mutual reinforcement across these domains.

Currently, LIANREN Digital Health has established a “three-circle” ecosystem for industry collaboration: first, by leveraging its shareholders’ advantages, it has secured partnerships across multiple sectors, including smart healthcare, commercial and social health insurance, and health management, thereby initially formingProduct Channel Ecosystem Partnership Circle; secondly, establish strategic partnerships with local governments and relevant institutions to obtain authorization for the operation of public data, thereby creatingGovernment Data Operations Cooperation Circle; by strengthening channel partnerships, effectively complementing direct sales operations, and reinforcing through complementary capabilities and valueEcosystem Collaboration Circle Across the Upstream and Downstream Industry Chain。

Traditional business practices place excessive emphasis on competition, constituting a zero-sum game; modern industries, particularly in the internet and technology sectors, should focus more on a co-opetition mindset, which represents a non-zero-sum game. “The foundation of co-opetition is multilateralism and openness.”Gao Jing, General Manager of LIANREN Digital HealthHe shared, “We liken the aggregation, governance, and application of big data in healthcare to a data superhighway. We warmly welcome enterprises across the upstream and downstream sectors to participate, leverage complementary strengths, and rapidly build a comprehensive highway network. This will drive high-quality industry development, contribute to the nation, and serve the public welfare.”

No sustainable industry can be established without seizing the opportunities of its time. In recent years, against the backdrop of China’s national “Digital Economy” strategy, the value of the data industry has risen, making the digital economy the most certain development trend in an era fraught with uncertainty.

The "China Internet Development Report 2022" reveals that in 2021, the scale of China's digital economy industry reached 45.5 trillion yuan, accounting for 39.8% of the GDP. Data has also been defined as a strategic foundational resource and a basic factor of production for national development.

With the advancement of emerging technologies such as big data, artificial intelligence, cloud computing, and 5G, the healthcare industry is accelerating its digital and intelligent transformation. However, despite the sector’s growing enthusiasm for unlocking the value of data, health and medical big data still faces significant challenges, including technical difficulties in data processing, operational pain points in scenario-based applications, and complex issues related to secure data sharing, openness, and management ownership.

Despite the significant challenges, stakeholders across the industry continue to explore new possibilities. After reviewing and summarizing these efforts, VCBeat identifies three increasingly intertwined pathways for “awakening” dormant healthcare data and transforming it into valuable applications:First, strengthen market-oriented reforms for data elements and adopt more flexible market mechanisms to translate concepts into practical implementation; second, establish a unified medical data sharing platform to break down data silos and transition data from fragmentation to centralization; third, progressively advance laws, regulations, and industry standards to bring order and standardization to health and medical big data.

Changes in the macroeconomic environment ultimately impact individuals. As one of the most dynamic forces in China’s economy, specialized and innovative enterprises like LIANREN Digital Health have been deeply involved in the growth and maturation of the medical big data industry, becoming a robust support for the industrial and supply chains of the “digital economy.” Whether recognized as a “potential unicorn” or accredited as a “specialized, refined, distinctive, and innovative enterprise,” sustained success has further fueled LIANREN Digital Health’s courage to explore the unknown.

After more than three years of practical business operations, LIANREN Digital Health has achieved a leading position in the industry in terms of business scale and market influence. This means that LIANREN Digital Health must assume the responsibility of an “industry leader,” possessing the capabilities to lead the pack and achieve self-breakthroughs, while exercising dominance in areas such as industry standard-setting, supply chain integration, and ecosystem convergence. For LIANREN Digital Health, this will be an extremely glorious yet immensely arduous Long March.